A Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus

Trial Profile

A Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2016

At a glance

  • Drugs Dacomitinib (Primary)
  • Indications Oesophageal cancer
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 05 Sep 2016 Status changed from recruiting to completed.
    • 24 Jul 2012 Actual initiation date (Jul 2012) added as reported by ClinicalTrials.gov.
    • 01 Jul 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top